Adviye Ergul Selected Research

Adviye Ergul Research Topics

Disease

60	Stroke (Strokes) 02/2024 - 08/2005
28	Ischemic Stroke 12/2021 - 02/2004
25	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 02/2004
21	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2005
18	Infarction (Infarctions) 01/2019 - 02/2004
15	Hypertension (High Blood Pressure) 01/2018 - 07/2002
13	Cognitive Dysfunction 02/2024 - 02/2015
13	Ischemia 09/2020 - 08/2005
12	Vascular Remodeling 08/2016 - 01/2002
11	Edema (Dropsy) 01/2023 - 08/2005
9	Hemorrhage 01/2021 - 08/2009
9	Brain Ischemia (Cerebral Ischemia) 10/2018 - 03/2006
8	Inflammation (Inflammations) 05/2023 - 07/2006
8	Hypoxia (Hypoxemia) 09/2020 - 08/2012
6	Reperfusion Injury 03/2017 - 08/2005
6	Hyperglycemia 06/2015 - 04/2005
5	Embolic Stroke 01/2019 - 12/2011
4	Body Weight (Weight, Body) 01/2016 - 06/2008
4	Obesity 02/2014 - 06/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2009 - 01/2004
3	Brain Injuries (Brain Injury) 02/2024 - 07/2006
3	Pathologic Neovascularization 01/2019 - 01/2013
3	Diabetic Angiopathies (Diabetic Angiopathy) 01/2017 - 01/2009
3	Insulin Resistance 02/2013 - 06/2008
2	Dementia (Dementias) 10/2022 - 07/2022
2	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 07/2022
2	Neuroinflammatory Diseases 09/2022 - 01/2021
2	Vascular System Injuries 12/2019 - 03/2013
2	Cerebral Hemorrhage 10/2017 - 12/2013
2	Diabetes Complications 06/2011 - 04/2005
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2009 - 02/2006
1	Anhedonia 02/2024
1	Brain Infarction 01/2023
1	Infections 07/2022

Drug/Important Bio-Agent (IBA)

20	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2002
16	Endothelin-1 (Endothelin 1)IBA 07/2022 - 07/2004
16	candesartanIBA 01/2022 - 03/2006
12	Proteins (Proteins, Gene)FDA Link 11/2020 - 07/2002
11	compound 21IBA 02/2024 - 03/2017
11	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 02/2006
10	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2018 - 09/2009
9	Endothelins (Endothelin)IBA 07/2022 - 11/2003
9	Minocycline (Cyclops)FDA LinkGeneric 10/2017 - 07/2006
8	Type 2 Angiotensin ReceptorIBA 02/2024 - 03/2017
8	salicylhydroxamic acid (SHAM)IBA 11/2020 - 10/2013
8	Blood Glucose (Blood Sugar)IBA 08/2016 - 01/2009
7	Hemoglobins (Hemoglobin)IBA 10/2018 - 07/2004
7	CollagenIBA 06/2009 - 01/2002
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2011
6	Peroxynitrous Acid (Peroxynitrite)IBA 02/2018 - 06/2012
6	AngiotensinsIBA 01/2018 - 01/2014
5	Vasoconstrictor AgentsIBA 07/2022 - 06/2006
5	SaltsIBA 12/2019 - 11/2003
5	Metformin (Glucophage)FDA LinkGeneric 08/2016 - 12/2010
5	Metalloproteases (Metalloproteinases)IBA 03/2016 - 08/2010
5	Endothelin Receptors (Endothelin Receptor)IBA 11/2014 - 04/2008
4	IronIBA 01/2023 - 02/2004
4	3-nitrotyrosineIBA 10/2016 - 11/2010
4	LinagliptinIBA 08/2016 - 01/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 01/2011
4	Insulin (Novolin)FDA Link 12/2013 - 06/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2023 - 01/2019
3	Oxygen (Dioxygen)IBA 03/2019 - 01/2014
3	InflammasomesIBA 01/2019 - 02/2014
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 02/2013
3	Neuroprotective AgentsIBA 10/2018 - 02/2004
3	Type 1 Angiotensin ReceptorIBA 08/2018 - 01/2015
3	Angiotensin Receptor AntagonistsIBA 08/2018 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 08/2009
3	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 02/2013
3	ThioredoxinsIBA 04/2015 - 01/2014
3	AntioxidantsIBA 04/2015 - 01/2005
3	LipidsIBA 09/2014 - 02/2013
3	Superoxides (Superoxide)IBA 11/2013 - 01/2004
3	Peptide Hydrolases (Proteases)FDA Link 06/2012 - 02/2006
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2022 - 09/2012
2	Drinking WaterIBA 01/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2016
2	Protective AgentsIBA 10/2017 - 08/2009
2	CytokinesIBA 03/2017 - 01/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2015
2	Bosentan (Tracleer)FDA Link 08/2016 - 11/2014
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 02/2013
2	Caspase 3 (Caspase-3)IBA 05/2015 - 01/2014
2	Staphylococcal Protein A (Protein A)IBA 04/2015 - 04/2015
2	Angiotensin II Type 1 Receptor BlockersIBA 11/2014 - 02/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014 - 06/2008
2	Messenger RNA (mRNA)IBA 01/2014 - 07/2002
2	CholesterolIBA 02/2013 - 11/2010
2	Desoxycorticosterone Acetate (DOCA)FDA Link 06/2008 - 11/2003
2	AtrasentanIBA 06/2008 - 08/2007
1	CeramidesIBA 02/2024
1	p38 Mitogen-Activated Protein KinasesIBA 09/2022
1	Amyloid beta-PeptidesIBA 09/2022
1	Lamin Type A (Lamin A)IBA 07/2022

Therapy/Procedure

13	Therapeutics 10/2022 - 08/2009
6	Sutures (Suture) 01/2019 - 09/2009
5	Glycemic Control 11/2014 - 04/2009
2	Thrombolytic Therapy 08/2014 - 07/2006